Recent studies have shown CB2 expression in hippocampal, striatal, and dopaminergic neurons, suggesting the potential for CB2 modulation for the treatment of disorders including pain, addiction, and schizophrenia [1,13,14,15,47,62,63]. The gene discussed is CNR2; the disease is schizophrenia.